Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Inhibition of VEGFR-2 reverses type 1 diabetes in NOD mice by abrogating insulitis and restoring islet function.

Villalta SA, Lang J, Kubeck S, Kabre B, Szot GL, Calderon B, Wasserfall C, Atkinson MA, Brekken RA, Pullen N, Arch RH, Bluestone JA.

Diabetes. 2013 Aug;62(8):2870-8. doi: 10.2337/db12-1619. Epub 2013 Jul 8.

2.

Glucose and inflammation control islet vascular density and beta-cell function in NOD mice: control of islet vasculature and vascular endothelial growth factor by glucose.

Akirav EM, Baquero MT, Opare-Addo LW, Akirav M, Galvan E, Kushner JA, Rimm DL, Herold KC.

Diabetes. 2011 Mar;60(3):876-83. doi: 10.2337/db10-0793. Epub 2011 Feb 9.

3.

Dipeptidyl peptidase IV inhibition activates CREB and improves islet vascularization through VEGF-A/VEGFR-2 signaling pathway.

Samikannu B, Chen C, Lingwal N, Padmasekar M, Engel FB, Linn T.

PLoS One. 2013 Dec 11;8(12):e82639. doi: 10.1371/journal.pone.0082639. eCollection 2013.

4.

Rapamycin/GABA combination treatment ameliorates diabetes in NOD mice.

He S, Zhang Y, Wang D, Tao K, Zhang S, Wei L, Chen Q.

Mol Immunol. 2016 May;73:130-7. doi: 10.1016/j.molimm.2016.01.008. Epub 2016 Apr 12.

PMID:
27082922
5.

Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice.

Louvet C, Szot GL, Lang J, Lee MR, Martinier N, Bollag G, Zhu S, Weiss A, Bluestone JA.

Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18895-900. doi: 10.1073/pnas.0810246105. Epub 2008 Nov 17.

7.
11.

IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.

Cameron MJ, Arreaza GA, Zucker P, Chensue SW, Strieter RM, Chakrabarti S, Delovitch TL.

J Immunol. 1997 Nov 15;159(10):4686-92.

PMID:
9366391
12.

Sex-specific effect of insulin-dependent diabetes 4 on regulation of diabetes pathogenesis in the nonobese diabetic mouse.

Ivakine EA, Fox CJ, Paterson AD, Mortin-Toth SM, Canty A, Walton DS, Aleksa K, Ito S, Danska JS.

J Immunol. 2005 Jun 1;174(11):7129-40.

13.

TAK1 inhibition prevents the development of autoimmune diabetes in NOD mice.

Cao H, Lu J, Du J, Xia F, Wei S, Liu X, Liu T, Liu Y, Xiang M.

Sci Rep. 2015 Oct 13;5:14593. doi: 10.1038/srep14593.

14.

Effects of insulin like growth factor-1 and insulin on effector T cells generating autoimmune diabetes.

Bergerot I, Fabien N, Thivolet C.

Diabetes Metab. 1996 Jul;22(4):235-9.

PMID:
8767168
15.

Essential role for signal transducer and activator of transcription-1 in pancreatic beta-cell death and autoimmune type 1 diabetes of nonobese diabetic mice.

Kim S, Kim HS, Chung KW, Oh SH, Yun JW, Im SH, Lee MK, Kim KW, Lee MS.

Diabetes. 2007 Oct;56(10):2561-8. Epub 2007 Jul 9.

16.
17.

Study on pancreatic lymphatics in nonobese diabetic mouse with prevention of insulitis and diabetes by adjuvant immunotherapy.

Qu P, Ji RC, Shimoda H, Miura M, Kato S.

Anat Rec A Discov Mol Cell Evol Biol. 2004 Dec;281(2):1326-36.

18.

Beta-cell destruction in NOD mice correlates with Fas (CD95) expression on beta-cells and proinflammatory cytokine expression in islets.

Suarez-Pinzon W, Sorensen O, Bleackley RC, Elliott JF, Rajotte RV, Rabinovitch A.

Diabetes. 1999 Jan;48(1):21-8.

PMID:
9892218
19.

Role of infiltrating T cells for impaired glucose metabolism in pancreatic islets isolated from non-obese diabetic mice.

Strandell E, Sandler S, Boitard C, Eizirik DL.

Diabetologia. 1992 Oct;35(10):924-31.

PMID:
1451948
20.

Vascular addressins are induced on islet vessels during insulitis in nonobese diabetic mice and are involved in lymphoid cell binding to islet endothelium.

Hänninen A, Taylor C, Streeter PR, Stark LS, Sarte JM, Shizuru JA, Simell O, Michie SA.

J Clin Invest. 1993 Nov;92(5):2509-15.

Supplemental Content

Support Center